Gene Expression Reagent Trends: Market Research Report

December 2013 | 15 pages | ID: GA82A09B8EDEN
Global Industry Analysts, Inc

Abstracts

Gene Expression refers to the production of functional products, most commonly proteins, using information saved in a specific gene. Gene expression is a key process undertaken by all life forms, including unicellular as well as multicellular organisms, primarily for generating their macromolecular machinery.

The report analyzes and presents an overview of Gene Expression Reagents market worldwide. Supported with 3 market data tables, the report provides a review of global market trends, and various strategic industry activities of major companies witnessed by the industry over the last few years. In addition, 30 companies operating in the Gene Expression Reagents arena worldwide including Affymetrix Inc., Agilent Technologies Inc., GE Healthcare, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific Inc., and others are profiled.

Contents

1. GENE EXPRESSION REAGENTS – AN OVERVIEW

An Introduction

Table 1. Major Individual qPCR Reagent Players Market Share by Value (2012) for Life Technologies Corporation, Roche Applied Science, Bio-Rad Laboratories Inc. , Qiagen, and Others

Table 2. Global Top 3 Gene Sequencing Tool Manufacturers’ Market Share by Value (2012) for Illumina, Roche, Life Sciences, and Others

Table 3. Global Top 3 Life Science Instrument Manufacturers’ Market Shares by Value (2012) for Life Technologies, Becton Dickinson, GE Healthcare, and Others

2. RECENT INDUSTRY ACTIVITY

Sigma-Aldrich Inks Agreement with Olink Bioscience
Synpromics Receives Grant from Technology Strategy Board
Thermo Fisher Scientific to Acquire Life Technologies
Agilent Technologies Inks Licensing Agreement with SRI International
Agilent Technologies Inks Agreement with Roche
ZyGEM Corp Signs Agreement with Quanta BioSciences
Affymetrix Receives US FDA Clearance for Gene Profiling Reagents

3. PRODUCT LAUNCHES/TECHNOLOGICAL INNOVATIONS

Agilent Technologies Launches SureScanDx Microarray Scanner
Illumina Introduces Universal Real-Time PCR Reagent Portfolio
Life Technologies Introduces Compendia Oncomine Next Generation Sequencing Power Tools
Mirus Bio Develops TransIT-BrCa Transfection Reagent
Affymetrix Launches Axiom Genotyping Arrays
Affymetrix Introduces SensationPlus FFPE Reagent Kit
Agilent Technologies Unveils Agilent SurePrint G3 Human Gene Expression v2 Microarray
Agilent Unveils Agilent CytoGenomics 1. 0
Agilent Technologies Introduces GeneSpring GX 11. 5 Bioinformatics Software
Agilent Technologies Unveils New Exon Analysis Solution

4. MARKET PARTICIPANTS

Affymetrix, Inc. (USA)
Agendia, Inc. (USA)
Agilent Technologies, Inc. (USA)
Applied Biosystems, Inc. (USA)
Cepheid (USA)
Clontech Laboratories, Inc. (USA)
Complete Genomics, Inc. (USA)
Cytocell Ltd. (UK)
DNA LandMarks, Inc. (Canada)
DNAVision SA (Belgium)
Dynex Technologies, Inc. (USA)
Epicentre Biotechnologies (USA)
Eurofins Medigenomix GmbH (Germany)
Eurogentec SA (Belgium)
Exiqon A/S (Denmark)
GE Healthcare (UK)
Geneworks Pty. , Ltd. (Australia)
Genisphere LLC (USA)
Illumina, Inc. (USA)
Inqaba Biotechnical Industries Pty. , Ltd. (South Africa)
Life Technologies Corporation (USA)
Mirus Bio LLC (USA)
Ocimum Biosolutions Ltd. (India)
Origene Technologies, Inc. (USA)
Quanta Biosciences, Inc. (USA)
Roche Diagnostics (Switzerland)
Saturn Biotech Ltd. (Australia)
Sequetech Corporation (USA)
Sigma-Aldrich Co. LLC (USA)
Thermo Fisher Scientific, Inc. (USA)

5. APPENDIX